Your browser doesn't support javascript.
loading
Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial.
Liang, Hanting; Wang, Ou; Cheng, Zhifeng; Xia, Peijin; Wang, Liang; Shen, Jie; Kong, Xijian; Zeng, Yuhong; Chao, Aijun; Yan, Limei; Lin, Hua; Sun, Haibiao; Cheng, Qun; Zhu, Mei; Hu, Zhenming; Zhang, Zhenlin; Tang, Hai; Xia, Weibo.
Afiliación
  • Liang H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
  • Wang O; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
  • Cheng Z; Department of Endocrinology, The Fourth Affiliated Hospital of Harbin Medical University, China.
  • Xia P; Department of Endocrinology, The Central Hospital of Fuling District, China.
  • Wang L; Department of Geriatric Medicine, The Eighth Medical Center of Chinese PLA General Hospital, China.
  • Shen J; Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Southern Medical University, China.
  • Kong X; Osteoporosis Medical Center, Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital), China.
  • Zeng Y; Department of Osteoporosis, Honghui Hospital of Xi'an Jiaotong University Medical School, China.
  • Chao A; Department of Osteoporosis, Tianjin Hospital of Tianjin City, China.
  • Yan L; Department of Endocrinology, Changchun Central Hospital, China.
  • Lin H; Department of Orthopedic, Nanjing Drum Tower Hospital (the Affiliated Hospital of Nanjing University Medical School), China.
  • Sun H; Department of Orthopedic, First Hospital of Shanxi Medical University, China.
  • Cheng Q; Department of Osteoporosis, Huadong Hospital Affiliated to Fudan University, China.
  • Zhu M; Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, China.
  • Hu Z; Department of Orthopedic, The First Affiliated Hospital of Chongqing Medical University, China.
  • Zhang Z; Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, China.
  • Tang H; Department of Orthopedic, Beijing Friendship Hospital, Capital Medical University, China.
  • Xia W; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
J Orthop Translat ; 35: 53-61, 2022 Jul.
Article en En | MEDLINE | ID: mdl-36090002

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: J Orthop Translat Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: J Orthop Translat Año: 2022 Tipo del documento: Article País de afiliación: China